YHN Acquisition I Ltd
YHNANasdaqFinancials · Blank Checks · D8 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | |
|---|---|---|
| Revenue | — | — |
| Operating income | — | — |
| Net income | $1.3M | $502,638 |
| Total assets | $27.2M | $61.8M |
| Total liabilities | $2.3M | $1.6M |
| Equity | −$2.2M | −$905,321 |
| EPS (diluted) | — | — |
| Shares out. | 7.8M | 1.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −60.4%
- Return on assets
- 4.9%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 8.6%
- Debt / equity
- —
- Book value / share
- $-0.28
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 163.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 8.9%moderate
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 1 good- Negative shareholder equity
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 59 | 9.8 | -1.7% |
| Apr 30, 2026 | 60 | 1.0 | -21.1% |
| Apr 15, 2026 | 76 | 1.0 | -14.6% |
| Mar 31, 2026 | 89 | 4.5 | 0.0% |
| Mar 13, 2026 | 89 | 5.2 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeApr 20, 2026
- Other material eventMar 23, 2026
- Entered a material agreementDec 17, 2025
- Other material eventDec 16, 2025
- Entered a material agreement · Amended charter or bylaws · Shareholder vote · Other material eventDec 10, 2025
- Entered a material agreementNov 10, 2025
- Entered a material agreementOct 15, 2025
- Director / officer changeJul 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QFORM 10-Q FOR MAR 2026May 14, 2026
- 8-KFORM 8-KApr 20, 2026
- SCHEDULE 13G/AApr 7, 2026
- 10-KFORM 10-K FOR DEC 2025Mar 31, 2026
- 4/AMar 31, 2026
- 8-KFORM 8-KMar 23, 2026
- SCHEDULE 13G/AFeb 13, 2026
- SCHEDULE 13G/AFeb 12, 2026
- SCHEDULE 13G/AFeb 11, 2026
- SCHEDULE 13G/AFeb 2, 2026
- SCHEDULE 13G/AJan 7, 2026
- 8-KFORM 8-KDec 17, 2025
- 8-KFORM 8-KDec 16, 2025
- 8-KCURRENT REPORTDec 10, 2025
- DEF 14ANov 14, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.